Viracta Therapeutics (VIRX) 10-Q2007 Q1 Quarterly report

Filed: 9 May 07, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: academic, annum, asset, belief, Bristol, Code, collectibility, compliance, Dr, entitled, enzyme, Europe, field, founder, fragment, GECC, history, inflation, insignificant, key, Kingdom, longer, member, middle, monthly, negotiation, noncreditable, nonrefundable, notice, ownership, percent, Ph, precluded, President, produced, SARcode, sell, Senior, temporary, UCSF, uncertainty, University, utilization, utilizing, Vice, written

Removed: absorb, accelerated, account, aforementioned, alternative, application, applied, Bulletin, calculating, cancelled, classified, closing, commitment, comparability, comparative, complex, comply, Conclusion, consecutive, consistency, continued, conversion, dedicate, demanding, difficult, diversify, environment, establish, established, exclude, executed, expand, expanded, favor, file, forma, guidance, headcount, increasingly, investigational, lack, larger, leasehold, manage, mature, measured, modified, occurred, operate, operational, Opinion, original, originally, party, payable, performance, pipeline, pool, predecessor, pro, projected, promissory, protocol, quantify, recognition, recording, reduction, refinement, requisite, resource, retain, retained, review, running, simplified, ultimately, view

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

VIRX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.2

Certification of Chief Financial Officer

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Sunesis Pharmaceuticals, Inc. (the “Company”) hereby certifies, to such officer’s knowledge, that:

(i) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2007 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2007	/s/ Eric H. Bjerkholt
	Eric H. Bjerkholt
	Senior Vice President, Corporate Development and Finance, Chief Financial Officer